BiomX Inc. (NYSEAMERICAN:PHGE – Get Free Report) dropped 0.7% on Monday . The company traded as low as $0.87 and last traded at $0.87. Approximately 27,301 shares changed hands during trading, a decline of 74% from the average daily volume of 105,003 shares. The stock had previously closed at $0.88.
BiomX Trading Down 0.7 %
The firm has a market capitalization of $15.64 million, a P/E ratio of -0.21 and a beta of 1.29.
BiomX (NYSEAMERICAN:PHGE – Get Free Report) last issued its quarterly earnings data on Wednesday, August 14th. The company reported $0.70 EPS for the quarter, topping analysts’ consensus estimates of ($1.20) by $1.90. Equities research analysts forecast that BiomX Inc. will post -2.7 EPS for the current fiscal year.
About BiomX
BiomX Inc, a clinical-stage microbiome company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria. It targets bacteria that affect the appearance of skin, as well as chronic diseases, such as inflammatory bowel diseases (IBD), primary sclerosing cholangitis (PSC), cystic fibrosis (CF), atopic dermatitis, and colorectal cancer (CRC).
Featured Articles
- Five stocks we like better than BiomX
- Breakout Stocks: What They Are and How to Identify Them
- Inflation Risk Rising, Key Trades Investors Are Making Now
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- 3 Oil Stocks to Watch Before Earnings Come Out
- Market Cap Calculator: How to Calculate Market Cap
- Is American Express Stock’s Sell-the-News Reaction a Buying Opp?
Receive News & Ratings for BiomX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BiomX and related companies with MarketBeat.com's FREE daily email newsletter.
